<DOC>
	<DOC>NCT00924560</DOC>
	<brief_summary>This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.</brief_summary>
	<brief_title>A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females</brief_title>
	<detailed_description>Participants will be randomized to either a 91-day OC or a 28-day OC. Participants not seeking hormonal contraception who meet eligibility criteria will serve as a control group. Duration of the study for each study participant will be approximately 13 months.</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy postmenarchal adolescent female 1218 years old, nonpregnant, nonlactating Regular spontaneous menstrual cycles Body mass index (BMI): 18 kg/m² to &lt;30 kg/m², weight &lt; 200 lbs Others as dictated by the Food and Drug Administration (FDA)approved protocol Any contraindication to the use of oral contraceptives History of previous clinically significant adverse event while taking hormonal contraceptives Use of any medication which could significantly interfere with study assessments Others as dictated by FDAapproved protocol</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Adolescents</keyword>
	<keyword>Bone Mineral Density</keyword>
	<keyword>Oral Contraceptive</keyword>
</DOC>